Pharmacovigilance is an important means to ensure drug safety.With the rapid development of the pharmaceutical and healthcare fields,the drug safety monitoring system is continuously improving and the laws and regulations related to pharmacovigilance are gradually building in China.To establish a perfect unity of drug safety monitoring system and implement pharmacovigilance activities to be in line with international standards,this article introduces the definition,functions,characteristics and classification of WHO pharmacovigilance indicators (issue date: 2015) and its important values for the drug safety monitoring system in details.It is emphasized that the series of pharmacovigilance indicators in WHO are especially significant values for constructing the efficient and normative drug safety monitoring system in China.
Dipeptidyl peptidase -4 (DPP-4) inhibitors are a new type of drugs for diabetes.They have remarkable hypoglycemic effect and fewer adverse drug reactions.They do not increase the risk of hypoglycemia.Currently in clinic,DPP-4 inhibitors are often used in combination with metformin in type 2 diabetes mellitus (T2DM) patients.They can lower blood sugar and glycosylated hemoglobin (HbA1c),and do not gain body weight.They are well tolerated with a low incidence of hypoglycemia.The research progress of combination therapy of DPP-4 inhibitors and metformin was reviewed in this paper.
To classify and describe the resource distribution,morphological characteristics,chemical constituents,pharmacological effects and main active ingredient onychin from the literatures of Onychium japonicum.Thirty-five compounds have been isolated from this plant,including flavonoids,coumarins,and indene ketone.Pharmacological research showed that Onychium japonicum has anti-inflammatory,analgesic,detoxifying,spasmolytic,and antitumor effects.Onychin is the main active ingredient,and it has endothelial cells protection,anti-atherosclerosis and anti-tumor effects.